2024 Payer Outlook: Opportunities and Considerations
Executive Summary:
In anticipation of the year 2024, the healthcare payer sector faces a complex landscape marked by rising costs, technological advancements, regulatory changes, and evolving patient needs. Key considerations for payer executives include managing higher costs, leveraging artificial intelligence (AI), especially generative AI, for optimizing operations, maintaining government business resilience amidst regulatory shifts, addressing pharmacy value-chain complexities, and reevaluating the administrative-services-only segment.
Main Considerations:
1. Managing Higher Costs:
- Therapy Utilization: Effective but costly therapies like GLP-1s for diabetes and obesity, and precision oncology treatments contribute to increased utilization.
- Health System Labor Shortages: Persisting shortages impact costs, potentially leading to a 9% increase in employer insurance rates if a $100 billion health system cost increase is factored in.
- Cost Pass-Through: Employees may face increased medical service expenses, with some paying over 75% of discretionary income.
2. Leveraging AI for Optimization:
- Process Enhancement: Opportunities exist to optimize administrative and medical processes using AI, including generative AI, automation, and digital technology.
- Favorable Implications: Rapid adoption of AI could reduce costs across all payers, affecting health system management, benefit contracts, and more sophisticated proposal responses.
3. Government Business Resilience:
- Regulatory Changes Impact: Recent Medicare, Medicaid, and Individual market changes strain payer businesses.
- Competition Shift: The basis of competition may evolve from price to benefits, distribution, and retention, potentially leading to established players displacing disruptors.
4. Pharmacy Value-Chain Complexity:
- Member Experience: Prescription drug purchases are challenging due to limited choice and high out-of-pocket costs.
- Innovation Needed: Payers might explore alternative payment models, such as outcome-based or site-neutral payments, to manage costs effectively.
5. Reenergizing the Administrative-Services-Only Segment:
- Profitability Variability: ASO profitability ranges widely, with opportunities for greater pricing innovation and tailored product packages.
- Vendor Strategy: A shift towards building partnerships at scale based on shared risk, platform agility, and seamless integration could improve outcomes.
6. Unproven Business Models and Scale Partnerships:
- Vertical Integration Challenges: Investments in pharmacies, providers, and alternative care sites have yielded mixed results.
- Payer-Agnostic Assets: Access to new profit pools may be possible without achieving expected cost benefits.
- Point Solutions: Collectively, these can lead to administrative burdens and degraded consumer experiences, suggesting a need for a comprehensive vendor strategy.
Conclusion:
Payer executives must navigate these challenges while capitalizing on emerging opportunities, particularly in AI-driven optimization, resilient government business strategies, pharmacy innovation, and restructured administrative services. Strategic partnerships and a focus on outcome-based solutions are key to sustaining and growing in the dynamic healthcare landscape of 2024.
